1 1381 128 IMPACT OF NATUROPATHY, YOGA, AND DIETARY INTERVENTIONS AS ADJUVANT CHEMOTHERAPY IN THE MANAGEMENT OF STAGE II AND III ADENOCARCINOMA OF THE COLON. INTRODUCTION: NATUROPATHY, YOGA AND DIETARY INTERVENTIONS ARE KNOWN TO IMPROVE THE QUALITY OF LIFE IN CANCER PATIENTS. WE AIM TO EVALUATE THE EFFECT OF NATUROPATHY INTERVENTIONS ALONG WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WHO UNDERWENT SURGERY FOR ADENOCARCINOMA OF THE COLON. METHODS: A TOTAL OF 116 ADULT PATIENTS WERE RANDOMISED IN TO ONE OF THE TWO GROUPS; THE EXPERIMENTAL GROUP RECEIVED NATUROPATHY, YOGA AND DIETARY INTERVENTIONS AND THE CONTROL GROUP RECEIVED PSYCHO-SOCIAL COUNSELLING IN ADDITION TO STANDARD CHEMOTHERAPY. HAEMATOLOGICAL, BIOCHEMICAL AND PSYCHOLOGICAL EVALUATIONS WERE PERFORMED AT SET INTERVALS DURING A TOTAL PERIOD OF EIGHTEEN MONTHS STARTING FROM THE FIRST CYCLE OF ADJUVANT CHEMOTHERAPY. RESULTS: RESULTS SHOWED THAT THE OVERALL HEMOGLOBIN (P < 0.0001) AND CARCINOEMBRYONIC ANTIGEN (CEA) (P = 0.0038) LEVELS WERE STATISTICALLY SIGNIFICANT IN PATIENTS ON THE EXPERIMENTAL ARM. THE REST OF THE LABORATORY PARAMETERS, VIZ. TOTAL LEUKOCYTE COUNT, PLATELET COUNTS, AND SERUM CREATININE LEVELS, FOR OVERALL DATA WAS NOT STATISTICALLY SIGNIFICANT IN BOTH THE GROUPS. PSYCHOLOGICAL ATTRIBUTES SUCH AS ANXIETY, DEPRESSION, SYMPTOM SEVERITY, AND FUNCTIONAL LIVING INDEX: CANCER (FLIC) WERE FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.0001) IN THE EXPERIMENTAL SUBJECTS AS COMPARED WITH THOSE IN THE CONTROL. ON THE WHOLE, MEN BENEFITED MORE THAN WOMEN FROM THE STUDY INTERVENTIONS. CONCLUSIONS: WE CONCLUDE THAT YOGA AND NATUROPATHY INTERVENTIONS IN ADDITION TO CHEMOTHERAPY SHOW IMPROVEMENT IN OVERALL FUNCTIONAL LIFE INDEX ALONG WITH IMPROVEMENT IN HAEMOGLOBIN IN PATIENTS WITH STAGES II AND III ADENOCARCINOMA OF COLON. 2020 2 1818 42 PROSPECTIVE RANDOMIZED TRIAL OF STANDARD ANTIEMETIC THERAPY WITH YOGA VERSUS STANDARD ANTIEMETIC THERAPY ALONE FOR HIGHLY EMETOGENIC CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN SOUTH ASIAN POPULATION. AIM/BACKGROUND: CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IS ONE OF THE MOST DISTRESSING SIDE EFFECTS OF HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS. THERE HAVE BEEN CONTINUOUS EFFORTS IN THE DIRECTION TO CONTROL CINV BY MANY INVESTIGATORS. MATERIALS AND METHODS: RANDOMLY SELECTED PATIENTS WERE THOSE RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN GROUPED INTO YOGA AND STANDARD ANTIEMETIC THERAPY (N = 50) JUST BEFORE RECEIVING CHEMOTHERAPY AND CONTINUED FOR THE FOLLOWING DAYS AND OTHER GROUP (N = 50) RECEIVED ONLY THE STANDARD ANTIEMETIC AGENT. BOTH THE GROUPS WERE ASSESSED, FOLLOWED FOR ACUTE AND DELAYED ONSET OF CHEMOTHERAPY-INDUCED AND ANTICIPATORY NAUSEA AND VOMITING USING RADIATION THERAPY ONCOLOGY GROUP GRADING FOR THE SAME. WE ALSO ASSESSED THE QUALITY OF LIFE OF THE PATIENT USING THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL QUESTIONNAIRE. RESULTS: THE MEDIAN AGE GROUP OF THE PATIENTS WAS 51 YEARS WITH MALE:FEMALE RATIO 2:1, THE EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) PERFORMANCE STATUS WAS 0/1 IN 38% OF THE SELECTED POPULATION, WHILE ECOG 2 IN 62% OF THE PATIENTS. IN YOGA ARM, INSIGNIFICANT REDUCTION IN CHEMOTHERAPY-INDUCED NAUSEA (90% VS. 78%, P = 0.35) AND BUT SIGNIFICANT REDUCTION IN VOMITING (42% VS. 22%, P =0.01) WAS OBSERVED AS COMPARED TO THE STANDARD ANTIEMETICS ONLY ARM. THERE WAS A SIGNIFICANT REDUCTION IN GRADE 2 AND 3 NAUSEA (84% VS. 38% P < 0.01) AND VOMITING (14% VS. 0% P < 0.01). QUALITY OF LIFE IS ALSO SIGNIFICANTLY IMPROVED IN THE YOGA ARM, ESPECIALLY IN THE ECOG 2 PERFORMANCE STATUS. CONCLUSIONS: THIS STUDY CONCLUDES THAT YOGA ALONG WITH STANDARD ANTIEMETIC MEDICATION SHOULD BE A PART OF THE MANAGEMENT PLAN FOR THE CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY. 2019 3 748 30 EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. OBJECTIVE: THE PRESENT STUDY INVESTIGATES THE EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. DESIGN: THE PROSPECTIVE OBSERVATIONAL COHORT STUDY ENROLLED TWO STUDY GROUPS: THOSE RECEIVING TREATMENT FROM THE INTERNATIONAL SAHAJA YOGA RESEARCH AND HEALTH CENTER (MEDITATION GROUP) AND THOSE RECEIVING TREATMENT FROM THE MAHATMA GANDHI MISSION HOSPITAL (CONTROL GROUP). RESEARCHERS MEASURED QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE BEFORE AND AFTER TREATMENT. RESULTS: SIXTY-SEVEN (67) PARTICIPANTS IN THE MEDITATION GROUP AND 62 PARTICIPANTS IN THE CONTROL GROUP COMPLETED THE STUDY. THE TWO GROUPS WERE COMPARABLE IN DEMOGRAPHIC AND CLINICAL CHARACTERISTICS. AT BASELINE, THE MEDITATION GROUP HAD HIGHER QUALITY OF LIFE (P<0.001) THAN CONTROLS BUT SIMILAR ANXIETY LEVEL (P=0.74) TO CONTROLS. WITHIN-GROUP PRE- VERSUS POST-TREATMENT COMPARISONS SHOWED SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE IN THE MEDITATION GROUP (P<0.001), WHILE IN CONTROLS, QUALITY OF LIFE DETERIORATED AND THERE WAS NO IMPROVEMENT IN BLOOD PRESSURE. THE IMPROVEMENT IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL WAS GREATER IN THE MEDITATION GROUP. THE BENEFICIAL EFFECT OF MEDITATION REMAINED SIGNIFICANT AFTER ADJUSTING FOR CONFOUNDERS. CONCLUSIONS: MEDITATION TREATMENT WAS ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL. 2012 4 2461 32 YOGA AS A NOVEL ADJUVANT THERAPY FOR PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES. CONTEXT: RECENT STUDIES HAVE DEMONSTRATED THAT PHYSICAL ACTIVITY IS WELL TOLERATED BY PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) AND CAN HAVE ADDITIONAL BENEFITS AS AN ADJUVANT THERAPY TO PHARMACOLOGIC AGENTS, ESPECIALLY IF STARTED EARLY. TO DATE, NO STUDIES HAVE EXAMINED THE EFFECTS OF YOGA ON PATIENTS WITH IIMS. AIMS: THE AIM OF THIS STUDY WAS TO EVALUATE THE EFFECTS OF YOGA ON SELF-REPORTED DIFFICULTY IN PERFORMING ACTIVITIES OF DAILY LIVING (ADL) AND MUSCLE STRENGTH IN PATIENTS WITH MILD-TO-MODERATE IIMS. SUBJECTS AND METHODS: A LONGITUDINAL COHORT STUDY IN WHICH PARTICIPANTS WERE ASSESSED USING THE MYOSITIS ACTIVITIES PROFILE (MAP) AND MANUAL MUSCLE TESTING (MMT) BEFORE AND AFTER THE COMPLETION OF AN 8-WEEK INSTRUCTOR-GUIDED YOGA COURSE WAS PERFORMED. STATISTICAL ANALYSIS USED: WILCOXON SIGNED-RANKED TEST WAS PERFORMED FOR STATISTICAL ANALYSIS. RESULTS: THE AVERAGE POSTTREATMENT MAP SCORES OF SIX PARTICIPANTS DEMONSTRATED AN INCREASE OF 2.51 POINTS, WHILE THE AVERAGE MMT SCORE OF FOUR PARTICIPANTS DEMONSTRATED AN INCREASE OF 11 POINTS. CONCLUSIONS: THIS STUDY IS THE FIRST STUDY TO DATE TO EXAMINE THE EFFECT OF YOGA AS AN ADJUVANT COMPLEMENTARY THERAPY FOR PATIENTS WITH IIM. CONTINUED RESEARCH SHOULD BE DONE ON THE EFFECT OF YOGA AS AN ADJUVANT THERAPY, FOR IN ADDITION TO INCREASE IN MUSCLE STRENGTH AND ABILITY TO PERFORM ADL, YOGA MAY OFFER POTENTIAL IMPROVEMENTS IN MOOD, MENTAL HEALTH, AND SLEEP. 2021 5 2103 34 THE EFFECT OF YOGA ON FUNCTIONAL RECOVERY LEVEL IN SCHIZOPHRENIC PATIENTS. PURPOSE: THE OBJECTIVE OF THIS STUDY IS TO DETERMINE THE EFFECT OF YOGA ON FUNCTIONAL RECOVERY LEVEL IN SCHIZOPHRENIC PATIENTS. MATERIALS AND METHODS: THE STUDY WAS CONDUCTED IN QUASI-EXPERIMENTAL DESIGN WITH PRETEST-POSTTEST CONTROL GROUP. THE POPULATION OF THE STUDY CONSISTED OF SCHIZOPHRENIC PATIENTS WITH REGISTERED IN MALATYA AND ELAZIG COMMUNITY MENTAL HEALTH CENTERS AND REGULARLY GOING TO THESE CENTERS. THE SAMPLE GROUP OF THE STUDY CONSISTED OF TOTALLY 100 PATIENTS INCLUDING 50 PATIENTS IN THE EXPERIMENTAL GROUP AND 50 PATIENTS IN THE CONTROL GROUP WHO WERE SPECIFIED THROUGH POWER ANALYSIS AND CHOSEN BY USING RANDOM SAMPLING METHOD FROM THIS POPULATION. THE DATA WERE COLLECTED BETWEEN APRIL 2015 AND AUGUST 2015. 'PATIENT DESCRIPTION FORM' AND 'FROGS' WERE USED TO COLLECT THE DATA. YOGA WAS APPLIED TO PATIENTS IN THE EXPERIMENTAL GROUP. ANY INTERVENTION WAS NOT MADE TO PATIENTS IN THE CONTROL GROUP. PERCENTAGE DISTRIBUTION, ARITHMETIC MEAN, STANDARD DEVIATION, CHI-SQUARE, INDEPENDENT SAMPLES T TEST, AND PAIRED T TEST WERE USED TO ASSESS THE DATA. RESULTS: PATIENTS IN THE CONTROL AND EXPERIMENTAL GROUP PRETEST SUBSCALE AND THE TOTAL MEANS SCORES OF FROGS WAS FOUND TO BE LOW. IN THE POSTTEST SUBSCALE AND TOTAL MEANS SCORES OF FROGS IN THE EXPERIMENTAL GROUP WERE HIGHER THAN IN THE CONTROL GROUP AND THE DIFFERENCES BETWEEN THEM WERE FOUND TO BE STATISTICALLY SIGNIFICANT (P<0.05). IN THE EXPERIMENTAL GROUP PRETEST AND POSTTEST SUBSCALE AND TOTAL MEANS SCORES OF FR0GS WAS DETERMINED TO BE STATISTICALLY SIGNIFICANT (P<0.05). CONCLUSION: YOGA THAT APPLIED TO SCHIZOPHRENIC PATIENTS IT WAS DETERMINED TO INCREASED THE LEVEL OF FUNCTIONAL RECOVERY. IT CAN BE SUGGESTED THAT YOGA SHOULD BE USED AS AN COMPLEMENTARY METHOD IN NURSING PRACTISE IN ORDER TO INCREASE THE EFFECTIVENESS OF THE TREATMENT. 2016 6 2112 26 THE EFFECT OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN. BACKGROUND: IN RECENT DECADES, SEVERAL MEDICAL AND SCIENTIFIC STUDIES ON YOGA PROVED IT TO BE VERY USEFUL IN THE TREATMENT OF SOME DISEASES. THIS STUDY WAS CONDUCTED TO INVESTIGATE THE EFFECTS OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN LIVING IN ILAM, IRAN. METHODS: THIS STUDY IS A QUASI-EXPERIMENTAL STUDY WITH PRE-POST TEST. TO COLLECT DATA, THE QUESTIONNAIRE OF DASS-21 (DEPRESSION ANXIETY STRESS SCALE-21) WAS USED. FOR ELIGIBLE SAMPLES, HATHA YOGA EXERCISES AND TRAINING SESSIONS WERE HELD FOR 4 WEEKS (3 TIME/WEEKS; 60-70 MIN EACH) BY A SPECIALIST. DATA WERE ANALYZED USING SPSS VERSION 20. RESULTS: 52 WOMEN WITH A MEAN AGE OF 33.5 +/- 6.5 WERE INCLUDED FOR ANALYSIS. DEPRESSION, ANXIETY, AND STRESS DECREASED SIGNIFICANTLY IN WOMEN AFTER 12 SESSIONS OF REGULAR HATHA YOGA PRACTICE (P < 0.001). CONCLUSIONS: YOGA HAS AN EFFECTIVE ROLE IN REDUCING STRESS, ANXIETY, AND DEPRESSION. THUS, IT CAN BE USED AS COMPLEMENTARY MEDICINE. 2018 7 819 35 EFFECT OF YOGA ON DEPRESSION IN HYPOTHYROIDISM: A PILOT STUDY. BACKGROUND: THE PREVALENCE OF HYPOTHYROIDISM AMONG INDIAN WOMEN IS 15.8%. DEPRESSION IS FREQUENTLY REPORTED IN HYPOTHYROIDISM. YOGA IS AN EFFECTIVE INTERVENTION FOR DEPRESSION. HOWEVER, THE INFLUENCE OF YOGA ON DEPRESSION IN PATIENTS WITH HYPOTHYROIDISM HAS NOT BEEN STUDIED. AIM: THE PRESENT STUDY INVESTIGATED THE EFFECT OF A 3-MONTH INTEGRATED YOGA INTERVENTION (3-IY) ON DEPRESSION, LIPID INDICES, AND SERUM THYROID-STIMULATING HORMONE (STSH) LEVELS AMONG FEMALE PATIENTS HAVING HYPOTHYROIDISM, AND MILD-TO-MODERATE DEPRESSION. METHOD: THE PRESENT SINGLE-ARM PRE-POST DESIGN STUDY WAS CONDUCTED IN THIRTY-EIGHT WOMEN (AVERAGE AGE 34.2 +/- 4.7 YEARS). PARTICIPANTS RECEIVED A 3-IY COMPRISING ASANAS, PRANAYAMA, AND RELAXATION TECHNIQUES FOR 60 MIN DAILY (5 DAYS A WEEK). DEPRESSION, STSH, LIPID PROFILE INDICES, BODY MASS INDEX (BMI), FATIGUE, ANXIETY, AND STRESS WERE ASSESSED AT BASELINE AND AFTER 12 WEEKS. THYROID MEDICATION WAS KEPT CONSTANT DURING THE STUDY PERIOD. DATA WERE ANALYSED USING R STUDIO SOFTWARE. RESULT: A SIGNIFICANT (P < 0.05) REDUCTION IN DEPRESSION (58%), STSH (37%), BMI (6%), FATIGUE (64%), ANXIETY (57%), LIPID PROFILE INDICES (HLD INCREASED SIGNIFICANTY), AND STRESS (55%) LEVELS WAS OBSERVED AFTER 3 MONTHS, COMPARED WITH THE CORRESPONDING BASELINE LEVELS. CONCLUSION: THE 3-IY IS USEFUL FOR REDUCING DEPRESSION, DYSLIPIDEMIA, AND STSH IN WOMEN WITH HYPOTHYROIDISM AND DEPRESSION. FURTHER STUDIES WITH A LARGER SAMPLE SIZE AND A ROBUST RESEARCH DESIGN USING OBJECTIVE VARIABLES MUST BE CONDUCTED TO STRENGTHEN THE STUDY FINDINGS. 2021 8 2173 32 THE EFFECTS OF YOGA ON DYSPNEA, SLEEP AND FATIGUE IN CHRONIC RESPIRATORY DISEASES. PURPOSE: THIS STUDY WAS CARRIED OUT TO FIND OUT THE EFFECTS OF YOGA APPLIED TO CHRONIC RESPIRATORY DISEASE PATIENTS ON DYSPNEA, SLEEP QUALITY AND FATIGUE. MATERIAL AND METHOD: THE STUDY WAS CONDUCTED BETWEEN MAY AND AUGUST 2020 AS A RANDOMIZED CONTROLLED STUDY. 'PERSONAL INFORMATION FORM', 'RESPIRATORY FUNCTIONS MONITORING FORM', 'COPD AND ASTHMA FATIGUE SCALE (CAFS), "ASTHMA AND COPD SLEEP IMPACT SCALE (CASIS)" AND MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE (MMRC) WERE USED IN DATA COLLECTION. RESULTS: WHEN THE POST-TEST MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP WERE COMPARED, IT WAS FOUND THAT CAFS, CASIS AND MMRC MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL GROUP DECREASED POSITIVELY COMPARED TO THE PATIENTS IN THE CONTROL GROUP AND THE DIFFERENCE BETWEEN WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.05). CONCLUSION: YOGA HAS BEEN FOUND TO REDUCE THE SEVERITY OF DYSPNEA AND FATIGUE AND IMPROVE SLEEP QUALITY IN CHRONIC RESPIRATORY DISEASES. 2021 9 1637 29 MODULATION OF CARDIAC AUTONOMIC BALANCE WITH ADJUVANT YOGA THERAPY IN PATIENTS WITH REFRACTORY EPILEPSY. THE PRACTICE OF YOGA REGULATES BODY PHYSIOLOGY THROUGH CONTROL OF POSTURE, BREATHING, AND MEDITATION. EFFECTS OF YOGA ON AUTONOMIC FUNCTIONS OF PATIENTS WITH REFRACTORY EPILEPSY, AS QUANTIFIED BY STANDARDIZED AUTONOMIC FUNCTION TESTS (AFTS), WERE DETERMINED. THE YOGA GROUP (N=18) RECEIVED SUPERVISED TRAINING IN YOGA, AND THE EXERCISE GROUP (N=16) PRACTICED SIMPLE ROUTINE EXERCISES. AFTS WERE REPEATED AFTER 10 WEEKS OF DAILY SESSIONS. DATA WERE COMPARED WITH THOSE OF HEALTHY VOLUNTEERS (N=142). THE YOGA GROUP SHOWED SIGNIFICANT IMPROVEMENT IN PARASYMPATHETIC PARAMETERS AND A DECREASE IN SEIZURE FREQUENCY SCORES. THERE WAS NO IMPROVEMENT IN BLOOD PRESSURE PARAMETERS IN EITHER GROUP. TWO PATIENTS IN THE YOGA GROUP ACHIEVED NORMAL AUTONOMIC FUNCTIONS AT THE END OF 10 WEEKS OF THERAPY, WHEREAS THERE WERE NO CHANGES IN THE EXERCISE GROUP. THE DATA SUGGEST THAT YOGA MAY HAVE A ROLE AS AN ADJUVANT THERAPY IN THE MANAGEMENT OF AUTONOMIC DYSFUNCTION IN PATIENTS WITH REFRACTORY EPILEPSY. 2008 10 2221 27 THE IMPACT OF LAUGHTER YOGA ON THE STRESS OF CANCER PATIENTS BEFORE CHEMOTHERAPY. BACKGROUND: CANCER IS USUALLY ACCOMPANIED BY CONSIDERABLE STRESS FOR THE SUFFERER, AND THE STRESS HAS DESTRUCTIVE EFFECTS ON CHEMOTHERAPY TREATMENT PROCESS. THEREFORE, THE CURRENT RESEARCH DEALS WITH THE EFFECT OF YOGA LAUGHTER ON THE CANCER PATIENTS' STRESS BEFORE CHEMOTHERAPY. METHODS: IN THIS RESEARCH, AS THE FIRST STEP, 37 CANCER SUFFERERS , WHO HAD BEEN HOSPITALIZED IN SHOHADA TAJRISH HOSPITAL (BEHNAM DANESHPOOR CHARITY ORGANIZATION) AND HAD THE REQUIREMENTS NECESSARY FOR BEING TAKEN AS RESEARCH SAMPLES, WERE SELECTED FOR DATA COLLECTION. THE MENTIONED PATIENTS WERE CLASSIFIED RANDOMLY IN EXPERIMENTAL AND CONTROL GROUPS. COLLECTED DATA WERE ANALYZED BY THE MULTI-VARIABLE COVARIANCE ANALYSIS TEST. RESULTS: THE RESULTS SHOW THERE IS A MEANINGFUL DIFFERENCE IN THE STRESS AVERAGE BEFORE AND AFTER INTERFERENCE IN THE TEST GROUP (P<0.05). CONCLUSION: LAUGHTER YOGA CAN DECREASE THE STRESS IN CANCER SUFFERERS BEFORE CHEMOTHERAPY. 2014 11 1833 26 PSYCHOLOGICAL WELLNESS, YOGA AND QUALITY OF LIFE IN PATIENTS AFFECTED BY SCHIZOPHRENIA SPECTRUM DISORDERS: A PILOT STUDY. SCHIZOPHRENIA IS A SERIOUS PSYCHIATRIC DISORDER CHARACTERIZED BY POSITIVE SYMPTOMS, NEGATIVE SYMPTOMS AND NEUROCOGNITIVE DEFICITS. THE AIM OF THIS STUDY WAS TO ESTIMATE RELATIONSHIPS BETWEEN WELLNESS, YOGA AND QUALITY OF LIFE IN PATIENTS AFFECTED BY SCHIZOPHRENIA SPECTRUM DISORDERS. PARTICIPANTS WERE 30 PATIENTS WITH A DIAGNOSIS OF SCHIZOPHRENIA IN CARE AT THE REHABILITATIVE PSYCHIATRY AND RESEARCH VILLA CHIARA CLINIC IN MASCALUCIA (CATANIA, ITALY), AFTER THAT RANDOMLY ASSIGNED TO TWO GROUPS. THE FIRST GROUP FOLLOWED THE EXPERIMENTAL TREATMENT WITH SETS OF YOGA EXERCISES CONDUCTED BY A YOGA TRAINER AND A PSYCHIATRIST OR A CLINICAL PSYCHOLOGIST EXPERT IN YOGA, WHILE A SECOND CONTROL GROUP WAS TREATED WITH USUAL CARE. THE RESULTS REVEALED A SIGNIFICANT DIFFERENCE, BEFORE AND AFTER TREATMENT, BETWEEN THE EXPERIMENTAL GROUP AND THE CONTROL GROUP IN QUALITY OF LIFE. 2019 12 2319 32 TREATING THE CLIMACTERIC SYMPTOMS IN INDIAN WOMEN WITH AN INTEGRATED APPROACH TO YOGA THERAPY: A RANDOMIZED CONTROL STUDY. OBJECTIVE: TO STUDY THE EFFECT OF YOGA ON THE CLIMACTERIC SYMPTOMS, PERCEIVED STRESS, AND PERSONALITY IN PERIMENOPAUSAL WOMEN. DESIGN: ONE HUNDRED TWENTY PARTICIPANTS (AGES 40-55 Y) WERE RANDOMLY DIVIDED INTO TWO STUDY ARMS, IE, YOGA AND CONTROL. THE YOGA GROUP PRACTICED AN INTEGRATED APPROACH TO YOGA THERAPY COMPRISING SURYA NAMASKARA (SUN SALUTATION) WITH 12 POSTURES, PRANAYAMA (BREATHING PRACTICES), AND AVARTAN DHYAN (CYCLIC MEDITATION), WHEREAS THE CONTROL GROUP PRACTICED A SET OF SIMPLE PHYSICAL EXERCISES UNDER SUPERVISION OF TRAINED TEACHERS FOR 8 WEEKS (1 H DAILY, 5 DAYS PER WEEK). THE ASSESSMENTS WERE MADE BY GREENE CLIMACTERIC SCALE, PERCEIVED STRESS SCALE, AND EYSENCK'S PERSONALITY INVENTORY BEFORE AND AFTER THE INTERVENTION. RESULTS: OF THE THREE FACTORS OF THE GREENE CLIMACTERIC SCALE, THE MANN-WHITNEY TEST SHOWED A SIGNIFICANT DIFFERENCE BETWEEN GROUPS (P < 0.05) IN THE VASOMOTOR SYMPTOMS, A MARGINALLY SIGNIFICANT DIFFERENCE (P = 0.06) IN PSYCHOLOGICAL FACTORS BUT NOT IN THE SOMATIC COMPONENT. EFFECT SIZES WERE HIGHER IN THE YOGA GROUP FOR ALL FACTORS. THERE WAS A SIGNIFICANTLY GREATER DEGREE OF DECREASE IN PERCEIVED STRESS SCALE SCORES (P < 0.001, INDEPENDENT SAMPLES T TEST) IN THE YOGA GROUP COMPARED WITH CONTROLS (BETWEEN-GROUP ANALYSIS) WITH A HIGHER EFFECT SIZE IN THE YOGA GROUP (1.10) THAN THE CONTROL (0.27). ON THE EYSENCK'S PERSONALITY INVENTORY, THE DECREASE IN NEUROTICISM WAS GREATER (P < 0.05) IN THE YOGA GROUP (EFFECT SIZE = 0.43) THAN THE CONTROL GROUP (EFFECT SIZE = 0.21) WITH NO CHANGE IN EXTROVERSION IN EITHER THE YOGA OR CONTROL GROUP. CONCLUSIONS: EIGHT WEEKS OF AN INTEGRATED APPROACH TO YOGA THERAPY DECREASES CLIMACTERIC SYMPTOMS, PERCEIVED STRESS, AND NEUROTICISM IN PERIMENOPAUSAL WOMEN BETTER THAN PHYSICAL EXERCISE. 2008 13 2464 37 YOGA AS A THERAPEUTIC INTERVENTION IN THE MANAGEMENT OF DYSFUNCTIONAL UTERINE BLEEDING: A CONTROLLED PILOT STUDY. BACKGROUND: DYSFUNCTIONAL UTERINE BLEEDING (DUB) IS ONE OF THE MOST COMMON GYNECOLOGICAL DISORDERS ENCOUNTERED IN WOMEN DURING THE REPRODUCTIVE AGE. YOGA THERAPY HAS SHOWN PROMISING BENEFITS IN SEVERAL GYNECOLOGICAL DISORDERS. METHODS: THIRTY WOMEN BETWEEN THE AGES OF 20 AND 40 YEARS WITH PRIMARY DUB WERE RANDOMLY ASSIGNED TO A YOGA (N = 15) AND A WAITLIST CONTROL GROUP (N = 15). PARTICIPANTS IN THE YOGA GROUP RECEIVED A 3-MONTH YOGA MODULE AND WERE ASSESSED FOR HEMOGLOBIN VALUES, ENDOMETRIAL THICKNESS (ET), PICTORIAL BLOOD LOSS ASSESSMENT CHART (PBAC), STATE-TRAIT ANXIETY INVENTORY, PERCEIVED STRESS SCALE, AND PITTSBURGH SLEEP QUALITY INDEX (PSQI) BEFORE AND AFTER A 3-MONTH FOLLOW-UP PERIOD. RESULTS: AT THE END OF 3 MONTHS OF INTERVENTION, THE YOGA GROUP, UNLIKE THE CONTROL GROUP, REPORTED A SIGNIFICANT REDUCTION IN THE ANXIETY SCORES (P < 0.05) AND PERCEIVED STRESS (P < 0.05). THE PSQI SCORES INDICATED A REDUCTION IN SLEEP DISTURBANCES (P < 0.001) AND THE NEED FOR SLEEP MEDICATIONS (P < 0.01) AND HIGHER GLOBAL SCORES (P < 0.001). HOWEVER, THERE WERE NO CHANGES IN PBAC AND ET IN BOTH THE GROUPS. CONCLUSION: THE RESULTS INDICATE THAT YOGA THERAPY POSITIVELY IMPACTS THE OUTCOME OF DUB BY REDUCING THE PERCEIVED STRESS AND STATE ANXIETY AND IMPROVING THE QUALITY OF SLEEP. THIS WARRANTS LARGER CLINICAL TRIALS TO VALIDATE THE FINDINGS OF THIS PILOT STUDY. 2018 14 771 40 EFFECT OF YOGA AND AEROBICS EXERCISE ON SLEEP QUALITY IN WOMEN WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: THE AIM OF THIS STUDY WAS INVESTIGATING THE EFFECT OF 12 WEEKS OF YOGA AND AEROBIC EXERCISE (RUNNING ON A TREADMILL) ON THE SLEEP QUALITY IN WOMEN WITH TYPE 2 DIABETES. MATERIALS AND METHODS: 39 DIABETIC WOMEN WERE SELECTED FROM SEMNAN CITY WITH THE MEAN AGE OF 46.85+/-3.35 YEARS, WEIGHT OF 69.79+/-17.18 KG, HEIGHT OF 155.03+/-5.00, BMI OF 29.64+/-5.00 KG/M(2) WHO HAD A BACKGROUND OF DIABETES FOR 6.46+/-2.69 YEARS. THEY WERE THEN RANDOMLY DIVIDED INTO YOGA EXERCISE (N=15), AEROBIC EXERCISE (N=13), AND CONTROL GROUP (N=11). THE EXERCISE PROGRAM WAS PERFORMED FOR 12 WEEKS, THREE SESSIONS PER EACH WEEK. IN ORDER TO MEASURE THE SLEEP QUALITY, THE PITTSBURGH SLEEP QUALITY INDEX (PSQI) WAS USED. THE DATA WERE ANALYZED BY NON-PARAMETRIC WILCOXON AND KRUSKAL-WALLIS TEST AT SIGNIFICANCE LEVEL OF P<0.05. RESULTS: OVERALL SCORE OF SLEEP QUALITY IMPROVED AFTER SIX (P=0.001) AND 12 (P=0.001) WEEKS OF YOGA EXERCISE. ALSO, SIGNIFICANT EFFECT WAS OBSERVED AFTER 6 WEEKS OF AEROBIC EXERCISE (P=0.039). HOWEVER, THE POSITIVE EFFECT WAS DIMINISHED TO UNDER SIGNIFICANT LEVELS AFTER 12 WEEKS OF AEROBIC EXERCISE (P=0.154). KRUSKAL-WALLIS TEST SHOWED SIGNIFICANT DIFFERENCES BETWEEN YOGA AND AEROBIC GROUPS AFTER 12 WEEKS OF EXERCISE (P=0.002). NO SIGNIFICANT DIFFERENCES WERE OBSERVED IN CONTROL GROUPS IN ALL SITUATION. CONCLUSIONS: IT CAN BE CONCLUDED THAT YOGA EXERCISE IS MORE EFFECTIVE IN IMPROVING THE SLEEP QUALITY IN COMPARISON WITH THE SAME COURSE OF AEROBIC EXERCISE IN WOMEN SUFFERING FROM DIABETES TYPE 2. THUS, YOGA EXERCISE CAN BE SUGGESTED TO THESE PATIENTS. 2017 15 1081 35 EFFECTS OF YOGA ON SEXUAL FUNCTION IN WOMEN WITH METABOLIC SYNDROME: A RANDOMIZED CONTROLLED TRIAL. INTRODUCTION: FEMALE SEXUAL DYSFUNCTION IS AN IMPORTANT PUBLIC HEALTH ISSUE; IT HAS A HIGH GLOBAL PREVALENCE, BUT NO EFFECTIVE AND SAFE TREATMENT OPTIONS. THE PREVALENCE OF SEXUAL DYSFUNCTION IS HIGHER IN WOMEN WITH METABOLIC SYNDROME THAN IN THE GENERAL POPULATION. AIM: THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFICACY OF YOGA AS A TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME. METHODS: IN THIS RANDOMIZED, CONTROLLED STUDY, 41 WOMEN WITH METABOLIC SYNDROME (AGE 30-60 YEARS) WERE ASSIGNED TO A 12-WEEK YOGA EXERCISE GROUP (N=20) OR A WAIT-LISTED CONTROL GROUP (N=21). MAIN OUTCOME MEASURES: PRIMARY END POINTS WERE CHANGES IN TOTAL AND INDIVIDUAL DOMAIN SCORES ON THE FEMALE SEXUAL FUNCTION INDEX. RESULTS: THE 12-WEEK YOGA INTERVENTION RESULTED IN SIGNIFICANT IMPROVEMENT IN AROUSAL (0.74+/-1.18 VS. 0.16+/-0.82, RESPECTIVELY; P=0.042) AND LUBRICATION (0.72+/-1.12 VS. 0.06+/-0.87, RESPECTIVELY; P=0.008) COMPARED WITH THE CONTROL GROUP. SYSTOLIC BLOOD PRESSURE SHOWED SIGNIFICANTLY GREATER IMPROVEMENT IN THE YOGA GROUP THAN IN THE CONTROL GROUP AT THE 12-WEEK FOLLOW UP (-3.5+/-13.7 VS. 2.0+/-14.7, RESPECTIVELY; P=0.040). CONCLUSION: THESE FINDINGS SUGGEST THAT YOGA MAY BE AN EFFECTIVE TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME AS WELL AS FOR METABOLIC RISK FACTORS. 2013 16 527 47 COMPARISON OF LYMPHOCYTE APOPTOTIC INDEX AND QUALITATIVE DNA DAMAGE IN YOGA PRACTITIONERS AND BREAST CANCER PATIENTS: A PILOT STUDY. BACKGROUND: YOGA IS FOUND TO BE EFFECTIVE IN REDUCING STRESS LEVELS AND RADIATION-INDUCED DNA DAMAGE, AND IMPROVING THE QUALITY OF LIFE, IN BREAST CANCER PATIENTS. THE PRESENT STUDY WAS AIMED AT COMPARING THE APOPTOTIC INDEX (AI) AND DNA DAMAGE OF ADVANCED YOGA PRACTITIONERS WITH THOSE OF BREAST CANCER PATIENTS. MATERIALS AND METHODS: THIS CROSS-SECTIONAL PILOT STUDY COMPARED THREE GROUPS (N = 9 EACH) OF AGE-MATCHED SUBJECTS VIZ. (1) CARCINOMA BREAST PATIENTS IN STAGE II OR III UNDERGOING RADIATION THERAPY AFTER COMPLETING THREE CYCLES OF CHEMOTHERAPY; (2) SENIOR YOGA PRACTITIONERS WHO WERE PRACTICING ASANAS, PRANAYAMA AND MEDITATION DAILY FOR MORE THAN 10 YEARS; AND (3) NORMAL HEALTHY VOLUNTEERS. PERIPHERAL BLOOD LYMPHOCYTES WERE ISOLATED, AND QUALITATIVE DNA DAMAGE (QDD) AND AI WERE EVALUATED BY SINGLE-CELL GEL ELECTROPHORESIS ASSAY. APPROXIMATELY 500 CELLS WERE COUNTED IN EACH CASE. NUMBER OF CELLS THAT WERE NORMAL, UNDERGOING APOPTOSIS, AND WITH DNA DAMAGE WERE CATEGORIZED AND PERCENTAGES WERE CALCULATED. RESULTS: DATA BEING NORMALLY DISTRIBUTED, ONE-WAY ANALYSIS OF VARIANCE (ANOVA) SHOWED SIGNIFICANT INTERACTION BETWEEN GROUPS IN AI (P = 0.016) AND QDD (P = 0.045). ON POST-HOC ANALYSIS USING SCHEFFE TEST, AI WAS SIGNIFICANTLY LOWER IN NON-YOGA VOLUNTEERS AS COMPARED WITH THE BREAST CANCER GROUP (P = 0.019) AND QDD WAS SIGNIFICANTLY LOWER IN YOGA PRACTITIONERS WHEN COMPARED WITH NON-YOGA VOLUNTEERS (P = 0.047). CONCLUSION: CELLULAR DYSFUNCTION (QDD) REQUIRES RESTORATIVE MECHANISMS (AI) TO RESTORE THE SYSTEM TO A BALANCE. THE RESULTS OF THIS PILOT STUDY SHOW TRENDS, WHICH INDICATE THAT IN ILL-HEALTH, THERE IS INADEQUATE RESTORATIVE MECHANISMS (AI) ALTHOUGH DYSFUNCTION (QDD) IS HIGH. THROUGH REGULAR PRACTICE OF YOGA, CELLULAR DYSFUNCTION CAN BE LOWERED, THUS NECESSITATING REDUCED RESTORATIVE MECHANISMS. AI AND QDD COULD ALSO BE USEFUL INDICATORS FOR PREDICTING THE THREE ZONES OF HEALTH VIZ. DISEASE, HEALTH, AND POSITIVE HEALTH. 2013 17 277 34 ADDITIONAL PRACTICE OF YOGA BREATHING WITH INTERMITTENT BREATH HOLDING ENHANCES PSYCHOLOGICAL FUNCTIONS IN YOGA PRACTITIONERS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND AND OBJECTIVE: THE PRACTICE OF YOGA IS ASSOCIATED WITH ENHANCED PSYCHOLOGICAL WELLBEING. THE CURRENT STUDY ASSESSED THE CORRELATION BETWEEN THE DURATION OF YOGA PRACTICE WITH STATE MINDFULNESS, MIND-WANDERING AND STATE ANXIETY. ALSO, WE EXAMINED IF AN ADDITIONAL 20 MIN OF YOGA BREATHING WITH INTERMITTENT BREATH HOLDING (EXPERIMENTAL GROUP) FOR 8 WEEKS WOULD AFFECT THESE PSYCHOLOGICAL VARIABLES MORE THAN REGULAR YOGA PRACTICE (CONTROL GROUP) ALONE. METHODS: ONE HUNDRED SIXTEEN SUBJECTS WERE RANDOMLY ASSIGNED TO EXPERIMENTAL (N = 60) AND CONTROL (N = 56) GROUPS. STATE MINDFULNESS ATTENTION AWARENESS SCALE (SMAAS), MIND-WANDERING QUESTIONNAIRE (MWQ) AND STATE ANXIETY INVENTORY WERE ADMINISTERED AT BASELINE AND AT THE END OF 8 WEEKS. RESULTS: BASELINE ASSESSMENT REVEALED A POSITIVE CORRELATION BETWEEN DURATION OF YOGA PRACTICE WITH SMAAS SCORES AND NEGATIVE CORRELATION WITH MWQ AND STATE ANXIETY SCORES. AT THE END OF 8 WEEKS, BOTH GROUPS DEMONSTRATED ENHANCED PSYCHOLOGICAL FUNCTIONS, BUT THE EXPERIMENTAL GROUP RECEIVING ADDITIONAL YOGA BREATHING PERFORMED BETTER THAN THE GROUP PRACTICING YOGA ALONE. CONCLUSION: AN ADDITIONAL PRACTICE OF YOGA BREATHING WITH INTERMITTENT BREATH HOLDING WAS FOUND TO ENHANCE THE PSYCHOLOGICAL FUNCTIONS IN YOUNG ADULT YOGA PRACTITIONERS. 2018 18 459 44 CHANGES IN PAIN INTENSITY AND HEALTH RELATED QUALITY OF LIFE WITH IYENGAR YOGA IN NONSPECIFIC CHRONIC LOW BACK PAIN: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: NONSPECIFIC CHRONIC LOW BACK (NCLBP) PAIN IS PREVALENT AMONG ADULT POPULATION AND OFTEN LEADS TO FUNCTIONAL LIMITATIONS, PSYCHOLOGICAL SYMPTOMS, LOWER QUALITY OF LIFE (QOL), AND HIGHER HEALTHCARE COSTS. THE PURPOSE OF THIS STUDY WAS TO DETERMINE THE EFFICACY OF IYENGAR YOGA THERAPY ON PAIN INTENSITY AND HEALTH RELATED QUALITY OF LIFE (HRQOL) WITH NCLBP. AIM OF THE STUDY: TO COMPARE THE EFFECT OF IYENGAR YOGA THERAPY AND CONVENTIONAL EXERCISE THERAPY ON PAIN INTENSITY AND HRQOL IN NONSPECIFIC CHRONIC LOW BACK PAIN. MATERIALS AND METHODS: EXPERIMENTAL STUDY WITH RANDOM SAMPLING TECHNIQUE. SUBJECTS/INTERVENTION: SIXTY SUBJECTS WHO FULFILLED THE SELECTION CRITERIA WERE RANDOMLY ASSIGNED TO IYENGAR YOGA (YOGA GROUP, N = 30) AND CONTROL GROUP (EXERCISE GROUP, N = 30). PARTICIPANTS COMPLETED LOW BACK PAIN EVALUATION FORM AND HRQOL-4 QUESTIONNAIRE BEFORE THEIR INTERVENTION AND AGAIN 4 WEEKS AND 6 MONTH LATER. YOGA GROUP UNDERWENT 29 YOGIC POSTURES TRAINING AND EXERCISE GROUP HAD UNDERGONE GENERAL EXERCISE PROGRAM FOR 4 WEEKS. STATISTICS: REPEATED MEASURES ANALYSIS OF VARIANCE (ANOVA) WAS USED TO ANALYZE GROUP DIFFERENCES OVER TIME, WHILE CONTROLLING FOR BASELINE DIFFERENCES. RESULTS: PATIENTS IN BOTH GROUPS EXPERIENCED SIGNIFICANT REDUCTION IN PAIN AND IMPROVEMENT IN HRQOL. IN VISUAL ANALOGUE SCALE (VAS) YOGA GROUP SHOWED REDUCTION OF 72.81% (P = 0.001) AS COMPARED TO EXERCISE GROUP 42.50% (P = 0.001). IN HRQOL, YOGA GROUP SHOWED REDUCTION OF 86.99% (P = 0.001) AS COMPARED TO EXERCISE GROUP 67.66% (P = 0.001). CONCLUSION: THESE RESULTS SUGGEST THAT IYENGAR YOGA PROVIDES BETTER IMPROVEMENT IN PAIN REDUCTION AND IMPROVEMENT IN HRQOL IN NONSPECIFIC CHRONIC BACK PAIN THAN GENERAL EXERCISE. 2014 19 1571 40 MANAGEMENT OF MYOFASCIAL PAIN DYSFUNCTION SYNDROME WITH MEDITATION AND YOGA: HEALING THROUGH NATURAL THERAPY. AIMS AND OBJECTIVES: AIMS AND OBJECTIVES OF THE STUDY WERE TO STUDY THE EFFECTIVENESS OF RAJ-YOGA MEDITATION AND PRANAYAMA IN PATIENTS WITH MYOFASCIAL PAIN DYSFUNCTION SYNDROME (MPDS) AND COMPARED THE EFFECTS WITH ONGOING CONVENTIONAL NONINVASIVE TREATMENT MODALITIES. MATERIALS AND METHODS: THE STUDY COMPRISED 30 PATIENTS DIVIDED EQUALLY (10 EACH) INTO 3 GROUP, I.E., CONTROL GROUP (CONVENTIONAL, NONINVASIVE TREATMENT), EXPERIMENTAL A GROUP (CONVENTIONAL, NONINVASIVE TREATMENT WITH RAJ-YOGA MEDITATION THERAPY AND PRANAYAMA), AND EXPERIMENTAL B GROUP (RAJ-YOGA MEDITATION THERAPY AND PRANAYAMA ONLY). PARAMETERS SUCH AS PAIN, MOUTH OPENING, MANDIBULAR DEVIATION, INFLAMMATION, SWELLING, CLICKING, OCCLUSION, AND PSYCHOLOGIC EVALUATION SUCH AS ANXIETY, STRESS, AND DEPRESSION WERE ASSESSED BEFORE THE START OF THE STUDY AND AT WEEKLY INTERVALS FOR 3 MONTHS. RESULTS: POSTTREATMENT PAIN AND INFLAMMATION IMPROVED BOTH IN THE CONTROL GROUP AND EXPERIMENTAL A GROUP, BUT STATISTICALLY IT IS HIGHLY SIGNIFICANT IN THE EXPERIMENTAL A GROUP. FURTHERMORE, IT IS EFFECTIVE IMMEDIATELY AS WELL AS FOR A LONG PERIOD IN EXPERIMENTAL A GROUP. IMPROVEMENT IN MOUTH OPENING WAS STATISTICALLY HIGHLY SIGNIFICANT IN CONTROL GROUP BUT NOT IN THE EXPERIMENTAL GROUPS. POSTTREATMENT ANXIETY AND STRESS STATUS WAS IMPROVED WITH STATISTICALLY HIGHLY SIGNIFICANT RESULT IN THE EXPERIMENTAL A AND B. THE POSTTREATMENT DEPRESSION STATUS ALONG WITH MANDIBULAR DEVIATION, SWELLING, CLICKING, AND OCCLUSION HAS NOT IMPROVED SIGNIFICANTLY IN ANY OF THE GROUPS. INTERPRETATION AND CONCLUSION: RAJ-YOGA MEDITATION AND PRANAYAMA IN COMBINATION WITH CONVENTIONAL, NONINVASIVE, TREATMENT MODALITIES SHOWED PROMISING RESULTS IN MPDS PATIENTS AS COMPARED TO EITHER MODALITIES ALONE. 2018 20 1046 36 EFFECTS OF YOGA ON ANXIETY AND DEPRESSION FOR HIGH RISK MOTHERS ON HOSPITAL BEDREST. BACKGROUND: AND PURPOSE: IN RECENT YEARS, YOGA PRACTITIONERS HAVE JOINED FORCES WITH MEDICAL PROGRAMS TO APPROACH PATIENTS' WELL-BEING HOLISTICALLY. THIS STUDY IS A RANDOMIZED CONTROLLED TRIAL TO ASSESS THE EFFECTS OF A SPECIALIZED ADAPTED YOGA PROGRAM ON ANXIETY AND DEPRESSION FOR HIGH-RISK EXPECTANT MOTHERS ON BEDREST IN A HOSPITAL SETTING. MATERIALS AND METHODS: SEVENTY-NINE PREGNANT SUBJECTS ON PHYSICIAN ORDERED HOSPITALIZED BEDREST WERE RANDOMIZED INTO TWO GROUPS: RECEIVING BIWEEKLY YOGA SESSIONS (INTERVENTION GROUP) OR RECEIVING NO YOGA (CONTROL GROUP). DATA COLLECTION TOOL WAS THE HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) TO ASSESS OUTCOMES AFTER DELIVERY. RESULTS: YOGA, EVEN AS LITTLE AS THREE SESSIONS, SHOWED SIGNIFICANT IMPACT IN REDUCING ANXIETY AND DEPRESSION HIGH-RISK PREGNANT WOMEN ON HOSPITALIZED BEDREST. PERCEIVED ANXIETY AND DEPRESSION OVERALL SCORES WERE LOWER IN THE INTERVENTION GROUP THAN IN THE CONTROL GROUP (P < 0.001). CONCLUSION: RESULTS DEMONSTRATED THAT YOGA IS AN EFFECTIVE INTERVENTION TO DECREASE ANXIETY AND DEPRESSION IN HIGH-RISK ANTEPARTUM WOMEN ON HOSPITALIZED BEDREST. 2020